Latest News

 

Zogenix Viewpoints

 

Technology

10-01-14 Zogenix Submits Modified Formulation of Zohydro(R) ER With Potential Abuse Deterrent Properties for FDA Review
09-18-14 New Data Shows Zohydro(R) ER Reduced Pain and Improved Function in People With Chronic Pain
09-04-14 Education, Patient-Focused Approach to Treating Chronic Pain Are Keys to Preventing Opioid Abuse, Say Experts, Patients

 

Latest Entries:

  DosePro is a first-in-class, easy-to-use drug delivery system designed for self-administration of a pre-filled, single dose of liquid drug, subcutaneously, without a needle. DosePro offers benefits to patients including instant, easy dosing, less anxiety over self-injection, no need for sharps disposal, no risk of needle stick injury or contamination, and reliable performance.